Managing Challenges in the Assessment and Treatment of Cannabis Use Disorders
This interactive and case-based workshop will address the diagnosis of cannabis use disorder, implications of co-occurring disorders, evidence-based treatment options and strategies for engaging and treating youth.
PRICE/PURCHASE -- $125
You must sign in or register register on this site before purchasing using the link on the upper right corner of this page. Only after registering will you see the "Add to Cart" button. To purchase, scroll to the bottom of the page and choose your purchase option (member/non-member) and click "Add to Cart."
PHYSICIANS: The California Society of Addiction Medicine (CSAM) is accredited by the Institute for Medical Quality/California Medical Association to provide continuing medical education for physicians. CSAM takes responsibility for the content, quality and scientific integrity of this CME activity.
CSAM designates this live educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™ Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
This course has been approved by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 3.5 AMA/PRA Category 1 Credits™ for completing the Review Course.
Continuing education credit is also available for nurses, psychologists, pharmacists, physician assistants, therapists, and drug abuse counselors.
- Addiction medicine specialists who want an overview of the latest developments in the field and their relevance to clinical practice
- Primary care clinicians who want to get a better understanding of addiction and manage patients with addictions in their practice
- Public health officials who want an understanding of the current state of addiction treatment
- Non-physicians who are involved in the treatment of addiction
- Seth Ammerman, MD, Clinical Professor, Pediatrics - Adolescent Medicine, Stanford UniversitySchool of Medicine;
- Marcel Bonn-Miller, PhD, Research, Health Science Specialist, Center of Excellence in Substance Abuse Treatment and Education, VA Palo Alto Health Care System;
- Timmen Cermak, MD, Psychiatrist in private practice, Mill Valley, CA
All faculty members participating in this activity, and those who plan and/or review and therefore are in control of content, are requested to disclose any relevant financial relationship prior to the CME activity, including but not limited to specific commercial interests, financial remuneration received by faculty member or spouse, and what role or activity was performed for this remuneration. If a conflict of interest exists as a result of a financial relationship it will be resolved prior to the activity. A faculty member will not be allowed to present if the conflict is not or cannot be resolved.
Conference Planners: Itai Danovitch, MD; David Pating, MD, Ingeborg Schafhalter-Zoppoth, MD have no relevant financial relationships to disclose/
- Seth Ammerman, MD: No relevant financial relationship to disclose
- Marcel O. Bonn-Miller, PhD: Tilray (Division of Privateer Holdings) (Self) : Consulting Fees (e.g., advisory boards)
- Timmen Cermak, MD: No relevant financial relationship to disclose
- 3.50 AMA Category 1
At the end of this activity physicians should be able to
- diagnose cannabis use disorders in their patients;
- develop a treatment plan for paitents with co-occuring psychiatric issues;
- assess options in treating patients with cannabis use disorders